Elizabeth B. Hirsch, PharmD, RPH, FIDSA

home / authors / elizabeth-b-hirsch-pharmd-rph-fidsa

Hirsch, PharmD, FCCP, FIDSA, is an appointed reviewer to the Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing. She is also an associate professor at the University of Minnesota College of Pharmacy and runs the Hirsch Laboratory in the Department of Experimental and Clinical Pharmacology.

Articles

What’s New in 2023 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Morgan L. Bixby, BS;Dina Zheng, PharmD Candidate;Elizabeth B. Hirsch, PharmD, RPH, FIDSA

October 25th 2023

This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.

What’s New in 2022 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Elizabeth B. Hirsch, PharmD, RPH, FIDSA;Morgan L. Bixby, BS

October 26th 2022

The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing held a virtual winter meeting and a hybrid summer meeting in 2022. Ad hoc working groups have several breakpoint revisions underway for multiple organism-drug combinations.